[go: up one dir, main page]

CY1106408T1 - Γονιδιωματικη αλληλουχια του χλαμυδιου της πνευμονιας (chlamydia pneymoniae) και πολυπεπτιδια, τμηματα αυτων και χρησεις αυτων, ιδιως για τη διαγνωση, την προληψη και τη θepαπευτικη αντιμετωπιση λοιμωξης - Google Patents

Γονιδιωματικη αλληλουχια του χλαμυδιου της πνευμονιας (chlamydia pneymoniae) και πολυπεπτιδια, τμηματα αυτων και χρησεις αυτων, ιδιως για τη διαγνωση, την προληψη και τη θepαπευτικη αντιμετωπιση λοιμωξης

Info

Publication number
CY1106408T1
CY1106408T1 CY20071100360T CY071100360T CY1106408T1 CY 1106408 T1 CY1106408 T1 CY 1106408T1 CY 20071100360 T CY20071100360 T CY 20071100360T CY 071100360 T CY071100360 T CY 071100360T CY 1106408 T1 CY1106408 T1 CY 1106408T1
Authority
CY
Cyprus
Prior art keywords
polypeptides
chlamydia pneumoniae
relates
infection
diagnosis
Prior art date
Application number
CY20071100360T
Other languages
English (en)
Inventor
Remy Griffais
Susan K. Hoiseth
Robert J. Zagursky
Benjamin J. Metcalf
Joel A. Peek
Banumathi Sankaran
Leah Diane Fletcher
Original Assignee
Serono Genetics Institute S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IB1998/001890 external-priority patent/WO1999027105A2/en
Application filed by Serono Genetics Institute S.A. filed Critical Serono Genetics Institute S.A.
Publication of CY1106408T1 publication Critical patent/CY1106408T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Η εφεύρεση έχει ως αντικείμενό της την γονιδιωματική αλληλουχία και τις αλληλουχίες νουκλεοτιδίων που κωδικεύουν πολυπεπτίδια του Chlamydia Pneymoniae, όπως πολυπεπτίδια κυτταρικού φακέλου τα οποία εκκρίνονται ή είναι εξειδικευμένα, ή τα οποία συμμετέχουν στον μεταβολισμό, στη διαδικασία αντιγραφής ή στη λοιμοτοξικότητα, πολυπεπτίδια τα οποία κωδικεύονται από τέτοιες αλληλουχίες καθώς και φορείς που περιλαμβάνουν τις εν λόγω αλληλουχίες και κύτταρα ή ζώα τροποποιημένα με αυτούς τους φορείς. Η εφεύρεση αφορά επίσης σε μεταγραφικά γονιδιακά προϊόντα όπως, επί παραδείγματι, αντινοηματικά και ριβοενζυμικά μόρια, τα οποία δύνανται να χρησιμοποιηθούν για τον έλεγχο της αύξησης του μικροοργανισμού. Η εφεύρεση αφορά επίσης σε μεθόδους για την ανίχνευση αυτών των νουκλεϊνικών οξέων ή πολυπεπτιδίων και σε κιτ για την διάγνωση λοίμωξης από Chlamydia Pneymoniae. Η εφεύρεση αφορά επίσης σε μια μέθοδο για την επιλογή ενώσεων οι οποίες είναι σε θέση να διαμορφώνουν την βακτηριακή λοίμωξη και σε μια μέθοδο για τη βιοσύνθεση ή βιοαποικοδόμηση μορίων που παρουσιάζουν ενδιαφέρον με τη χρήση των εν λόγω αλληλουχιών νουκλεοτιδίων ή των εν λόγω πολυπεπτιδίων. Τέλος, η εφεύρεση περιλαμβάνει φαρμακευτικές συνθέσεις, ιδίως εμβόλια, για την πρόληψη και/ή θεραπευτική αντιμετώπιση βακτηριακών λοιμώξεων, ιδίως από Chlamydia Pneymoniae.
CY20071100360T 1997-11-21 2007-03-15 Γονιδιωματικη αλληλουχια του χλαμυδιου της πνευμονιας (chlamydia pneymoniae) και πολυπεπτιδια, τμηματα αυτων και χρησεις αυτων, ιδιως για τη διαγνωση, την προληψη και τη θepαπευτικη αντιμετωπιση λοιμωξης CY1106408T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9714673 1997-11-21
US10707898P 1998-11-04 1998-11-04
PCT/IB1998/001890 WO1999027105A2 (en) 1997-11-21 1998-11-20 Chlamydia pneumoniae genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection

Publications (1)

Publication Number Publication Date
CY1106408T1 true CY1106408T1 (el) 2011-10-12

Family

ID=9513667

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20071100360T CY1106408T1 (el) 1997-11-21 2007-03-15 Γονιδιωματικη αλληλουχια του χλαμυδιου της πνευμονιας (chlamydia pneymoniae) και πολυπεπτιδια, τμηματα αυτων και χρησεις αυτων, ιδιως για τη διαγνωση, την προληψη και τη θepαπευτικη αντιμετωπιση λοιμωξης

Country Status (6)

Country Link
US (4) US6559294B1 (el)
AT (1) ATE480625T1 (el)
CY (1) CY1106408T1 (el)
DE (1) DE69841894D1 (el)
ES (1) ES2352082T3 (el)
PT (1) PT1032674E (el)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7141244B1 (en) * 1992-03-02 2006-11-28 Chiron Srl Helicobacter pylori proteins useful for vaccines and diagnostics
WO1996001272A1 (en) * 1994-07-01 1996-01-18 Rican Limited Helicobacter proteins and vaccines
AU1463097A (en) * 1996-01-04 1997-08-01 Rican Limited Helicobacter pylori bacterioferritin
US6908770B1 (en) * 1998-07-16 2005-06-21 Board Of Regents, The University Of Texas System Fluid based analysis of multiple analytes by a sensor array
EP1135501A1 (en) * 1998-12-01 2001-09-26 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
NZ512730A (en) * 1998-12-04 2003-12-19 Univ Manitoba A immunization procedure against chlamydia infection using an attenuated bacteria comprsing a plasmid with a major outer membrane protein (MOMP) from chlamydial
US20080213264A1 (en) * 1998-12-08 2008-09-04 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US20020061848A1 (en) * 2000-07-20 2002-05-23 Ajay Bhatia Compounds and methods for treatment and diagnosis of chlamydial infection
US7297341B1 (en) * 1998-12-23 2007-11-20 Sanofi Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
EP1140999A1 (en) * 1998-12-23 2001-10-10 Aventis Pasteur Limited $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF
US6808713B1 (en) * 1998-12-28 2004-10-26 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
AU775695B2 (en) * 1999-03-12 2004-08-12 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
US20030095973A1 (en) * 1999-05-03 2003-05-22 Murdin Andrew D. Chlamydia antigens and corresponding DNA fragments and uses thereof
DE60037900T2 (de) * 1999-09-20 2009-02-12 Sanofi Pasteur Ltd., Toronto Chlamydia antigene und entsprechende dna-fragmente und ihre verwendungen
US6881720B1 (en) * 1999-09-21 2005-04-19 Japan Tabacco Inc. Antimicrobial protein from Lyophyllum shimeji
WO2001036455A2 (en) * 1999-11-12 2001-05-25 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
AU784193B2 (en) * 1999-12-22 2006-02-16 Sanofi Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
US20020071831A1 (en) * 2000-04-04 2002-06-13 Murdin Andrew D. Chlamydia antigens and corresponding DNA fragments and uses thereof
US20020082402A1 (en) * 2000-04-04 2002-06-27 Murdin Andrew D. Chlamydia antigens and corresponding DNA fragments and uses thereof
US6919187B2 (en) * 2000-04-21 2005-07-19 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US20040254130A1 (en) * 2000-05-08 2004-12-16 Murdin Andrew D Chlamydia antigens and corresponding dna fragments and uses thereof
WO2001090153A2 (en) * 2000-05-23 2001-11-29 Nexell Therapeutics, Inc. Reagents for cell selection and methods of use
EP1297005B1 (en) * 2000-07-03 2009-08-26 Novartis Vaccines and Diagnostics S.r.l. Immunisation against chlamydia pneumoniae
US7811592B2 (en) * 2000-08-16 2010-10-12 Auburn University Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of Chlamydia
DE60142693D1 (de) * 2000-09-08 2010-09-09 Daiichi Sankyo Co Ltd Arzneimittel für herzversagen
US7731980B2 (en) * 2000-10-02 2010-06-08 Emergent Product Development Gaithersburg Inc. Chlamydia PMP proteins, gene sequences and uses thereof
US7537772B1 (en) 2000-10-02 2009-05-26 Emergent Product Development Gaithersburg Inc. Chlamydia protein, gene sequence and the uses thereof
ATE420892T1 (de) * 2000-12-14 2009-01-15 Pasteur Institut Sekretierte chlamydia polypeptide und verfahren zur identifizierung davon über ihre sekretion durch gramnegativen bakterientyp iii sekretionsweg
US20070149474A1 (en) 2000-12-15 2007-06-28 Auburn University Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of chlamydia
US8206724B2 (en) * 2000-12-15 2012-06-26 Auburn University Method and compositions for vaccination comprising nucleic acid and/or polypeptide sequence of chlamydia
US20030059896A1 (en) * 2000-12-21 2003-03-27 Shire Biochem Inc. Novel chlamydia antigens and corresponding DNA fragments
EP1383922A4 (en) * 2001-04-10 2005-03-30 Agensys Inc NUCLEIC ACID AND ASSOCIATED PROTEIN SUITABLE FOR THE TREATMENT AND DETECTION OF CANCER WITH THE LABEL 158P3D2
JP2005506322A (ja) * 2001-08-31 2005-03-03 カイロン ソチエタ ア レスポンサビリタ リミタータ Ｈｅｌｉｃｏｂａｃｔｅｒｐｙｌｏｒｉワクチン接種
US20080112965A1 (en) * 2001-10-01 2008-05-15 Aventis Pasteur Limited Chlamydia OMP antigen
WO2003067399A2 (en) * 2002-02-07 2003-08-14 Byington Carrie L Method for creating and using a treatment protocol
WO2003090605A2 (en) * 2002-04-26 2003-11-06 Board Of Regents, The University Of Texas System Method and system for the detection of cardiac risk factors
CA2506738A1 (en) * 2002-11-22 2004-06-10 Wyeth Composition for treating chlamydia infections and method for identifying same
US20070003568A1 (en) * 2003-02-24 2007-01-04 Alice Dautry-Varsat Secreted chlamydia polypeptides, polynucleotides coding therefor, therapeutic and diagnostic uses thereof
WO2004113374A2 (en) * 2003-06-17 2004-12-29 Intercell Ag Chlamydia pneumoniae antigens
WO2005020785A2 (en) * 2003-07-15 2005-03-10 The Regents Of The University Of California Discovery of the microorganism that causes the human autoimmune disease, primary biliary cirrhosis
US8101431B2 (en) 2004-02-27 2012-01-24 Board Of Regents, The University Of Texas System Integration of fluids and reagents into self-contained cartridges containing sensor elements and reagent delivery systems
KR20120085921A (ko) * 2004-05-11 2012-08-01 압제노믹스 코오페라티에프 유.에이. Ｔ 세포 사멸 유도성 에피토프
WO2006086019A2 (en) * 2004-10-21 2006-08-17 Optiscan Biomedical Corporation Methods of treating diabetes
DE602006018586D1 (de) * 2005-02-07 2011-01-13 Gen Probe Inc Zusammensetzungen und verfahren zum nachweis von streptokokken der gruppe b
EP1910824A4 (en) 2005-05-31 2012-11-21 Labnow Inc METHOD AND COMPOSITIONS RELATED TO THE PREPARATION AND USE OF A WHITE BLOOD IMAGE
WO2006133385A2 (en) * 2005-06-06 2006-12-14 Gen-Probe Incorporated Compositions, methods and kits for determining the presence of chlamydophila pneumoniae in a test sample
EP1905825A1 (en) * 2006-09-29 2008-04-02 greenovation Biotech GmbH Galactosyltransferase
EP2099482A2 (en) * 2006-12-04 2009-09-16 Auburn University Chlamydia pneumoniae vaccine and methods for administering such a vaccine
US20090092969A1 (en) * 2007-10-09 2009-04-09 Michael Aye Detection of atypical pneumonia
US20130071421A1 (en) * 2009-10-02 2013-03-21 W. Ian Lipkin Turkey viral hepatitis virus and uses thereof
EP2557178B1 (en) * 2010-03-31 2014-11-26 Yamaguchi Technology Licensing Organization, Ltd. Method for detecting pneumonia causative bacteria using nucleic acid chromatography
KR101311886B1 (ko) 2010-05-26 2013-09-26 한국기초과학지원연구원 폐렴연쇄상구균의 분비단백질을 포함하는 폐렴 진단용 조성물
CA3037903A1 (en) * 2010-10-09 2012-04-26 Mayo Foundation For Medical Education & Research Human antibodies and diagnostic and therapeutic uses thereof for the treatment of neurological disease
EP3885366A3 (en) 2011-01-14 2021-12-29 The Regents of the University of California Therapeutic antibodies against ror-1 protein and methods for use of same
WO2014151011A1 (en) * 2013-03-15 2014-09-25 Georgetown University Selective inhibitor of angiotensin ii
CA2973220A1 (en) 2014-01-16 2015-07-23 Mcmaster University Type iii secretion injectisome proteins for treatment and prevention of chlamydial infections
CN114137209B (zh) * 2021-02-01 2024-03-01 中国水产科学研究院黄海水产研究所 一种快速检测牡蛎疱疹病毒抗原的免疫荧光检测试纸条及应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2321346T3 (es) 1994-09-20 2009-06-04 Hitachi Chemical Co., Ltd. Polinucleotidos que codifican un polipeptido antigenico de chlamydia pneumoniae.
US6493591B1 (en) * 2000-07-19 2002-12-10 Medtronic, Inc. Implantable active fixation lead with guidewire tip

Also Published As

Publication number Publication date
US20040006218A1 (en) 2004-01-08
US7101963B2 (en) 2006-09-05
DE69841894D1 (de) 2010-10-21
US6559294B1 (en) 2003-05-06
PT1032674E (pt) 2007-03-30
ATE480625T1 (de) 2010-09-15
US20090274701A1 (en) 2009-11-05
US7601531B2 (en) 2009-10-13
US20070053927A1 (en) 2007-03-08
ES2352082T3 (es) 2011-02-15

Similar Documents

Publication Publication Date Title
CY1106408T1 (el) Γονιδιωματικη αλληλουχια του χλαμυδιου της πνευμονιας (chlamydia pneymoniae) και πολυπεπτιδια, τμηματα αυτων και χρησεις αυτων, ιδιως για τη διαγνωση, την προληψη και τη θepαπευτικη αντιμετωπιση λοιμωξης
DK1032674T3 (da) Chlamydia pneumoniae genomisk sekvens og polypeptider, fragmenter deraf og anvendelser deraf, især til diagnosen, forebyggelsen og behandlingen af infektion
WO1999028475A3 (en) Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
Konarska et al. Replication of RNA by the DNA-dependent RNA polymerase of phage T7
Blum et al. Excision of large DNA regions termed pathogenicity islands from tRNA-specific loci in the chromosome of an Escherichia coli wild-type pathogen
Titok et al. Bacillus subtilis soil isolates: plasmid replicon analysis and construction of a new theta-replicating vector
Lund et al. Spacer transfer RNAs in ribosomal RNA transcripts of E. coli: processing of 30S ribosomal RNA in vitro
Acebo et al. Identification of 88 regulatory small RNAs in the TIGR4 strain of the human pathogen Streptococcus pneumoniae
Hagervall et al. Reduced misreading of asparagine codons by Escherichia coli tRNALys with hypomodified derivatives of 5-methylaminomethyl-2-thiouridine in the wobble position
NZ540544A (en) Nucleic acids and proteins from streptococcus groups A & B
WO2002053728A3 (en) Gene disruption methodologies for drug target discovery
DE60112746D1 (de) Kälteempfindliche dna-polymerasemutanten
KR20220147616A (ko) 재프로그래밍된 tracrRNA를 사용한 RNA 검출 및 전사-의존적 편집
Dwidar et al. Riboswitch signal amplification by controlling plasmid copy number
Puyet et al. Identification of the origin and direction of replication of the broad-host-range plasmid pLS1
Braun et al. A chimeric ribozyme in Clostridium difficile combines features of group I introns and insertion elements
Lapidus et al. Sequencing and functional annotation of the Bacillus subtilis genes in the 200 kb rrnB-dnaB region
ES2186745T3 (es) Procedimiento para la identificacion especifica en genero y especie de legionelas.
US6448016B1 (en) Nucleotide sequences for detection of Bacillus anthracis
Takahashi et al. Investigation of RecA—polynucleotide interactions from the measurement of LexA repressor cleavage kinetics: Presence of different types of complex
Pang et al. Copy number of the 16S rRNA gene in Rickettsia prowazekii
WO1996015264A3 (en) Method for identifying nucleic acid sequences from different biological sources through amplification of the same
Inokuchi et al. Structure and expression of prokaryotic tRNA genes
WO2001060975A3 (en) Gene disruption methodologies in fungi for drug target discovery
Santapaola et al. Enteroinvasive Escherichia coli virulence-plasmid-carried apyrase (apy) and ospB genes are organized as a bicistronic operon and are subject to differential expression